Literature DB >> 22578325

Smith-Magenis syndrome results in disruption of CLOCK gene transcription and reveals an integral role for RAI1 in the maintenance of circadian rhythmicity.

Stephen R Williams1, Deborah Zies, Sureni V Mullegama, Michael S Grotewiel, Sarah H Elsea.   

Abstract

Haploinsufficiency of RAI1 results in Smith-Magenis syndrome (SMS), a disorder characterized by intellectual disability, multiple congenital anomalies, obesity, neurobehavioral abnormalities, and a disrupted circadian sleep-wake pattern. An inverted melatonin rhythm (i.e., melatonin peaks during the day instead of at night) and associated sleep-phase disturbances in individuals with SMS, as well as a short-period circadian rhythm in mice with a chromosomal deletion of Rai1, support SMS as a circadian-rhythm-dysfunction disorder. However, the molecular cause of the circadian defect in SMS has not been described. The circadian oscillator temporally orchestrates metabolism, physiology, and behavior largely through transcriptional modulation. Data support RAI1 as a transcriptional regulator, but the genes it might regulate are largely unknown. Investigation into the role that RAI1 plays in the regulation of gene transcription and circadian maintenance revealed that RAI1 regulates the transcription of circadian locomotor output cycles kaput (CLOCK), a key component of the mammalian circadian oscillator that transcriptionally regulates many critical circadian genes. Data further show that haploinsufficiency of RAI1 and Rai1 in SMS fibroblasts and the mouse hypothalamus, respectively, results in the transcriptional dysregulation of the circadian clock and causes altered expression and regulation of multiple circadian genes, including PER2, PER3, CRY1, BMAL1, and others. These data suggest that heterozygous mutation of RAI1 and Rai1 leads to a disrupted circadian rhythm and thus results in an abnormal sleep-wake cycle, which can contribute to an abnormal feeding pattern and dependent cognitive performance. Finally, we conclude that RAI1 is a positive transcriptional regulator of CLOCK, pinpointing a novel and important role for this gene in the circadian oscillator.
Copyright © 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22578325      PMCID: PMC3370274          DOI: 10.1016/j.ajhg.2012.04.013

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  42 in total

1.  Beta 1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome.

Authors:  H De Leersnyder; J L Bresson; M-C de Blois; J-C Souberbielle; A Mogenet; B Delhotal-Landes; F Salefranque; A Munnich
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

2.  Refinement of the Smith-Magenis syndrome critical region to approximately 950kb and assessment of 17p11.2 deletions. Are all deletions created equally?

Authors:  Christopher N Vlangos; Dwight K C Yim; Sarah H Elsea
Journal:  Mol Genet Metab       Date:  2003-06       Impact factor: 4.797

Review 3.  DNA microarray time series analysis: automated statistical assessment of circadian rhythms in gene expression patterning.

Authors:  Martin Straume
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

4.  Mosaicism for del(17)(p11.2p11.2) underlying the Smith-Magenis syndrome.

Authors:  R C Juyal; A Kuwano; I Kondo; F Zara; A Baldini; P I Patel
Journal:  Am J Med Genet       Date:  1996-12-11

5.  Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2)

Authors:  F Greenberg; R A Lewis; L Potocki; D Glaze; J Parke; J Killian; M A Murphy; D Williamson; F Brown; R Dutton; C McCluggage; E Friedman; M Sulek; J R Lupski
Journal:  Am J Med Genet       Date:  1996-03-29

6.  Inactivation of Rai1 in mice recapitulates phenotypes observed in chromosome engineered mouse models for Smith-Magenis syndrome.

Authors:  Weimin Bi; Tomoko Ohyama; Hisashi Nakamura; Jiong Yan; Jaya Visvanathan; Monica J Justice; James R Lupski
Journal:  Hum Mol Genet       Date:  2005-03-03       Impact factor: 6.150

7.  Sleep disturbance in Smith-Magenis syndrome (del 17 p11.2).

Authors:  A C Smith; E Dykens; F Greenberg
Journal:  Am J Med Genet       Date:  1998-03-28

8.  Melatonin content of the pineal gland in different mouse strains.

Authors:  M Goto; I Oshima; T Tomita; S Ebihara
Journal:  J Pineal Res       Date:  1989       Impact factor: 13.007

9.  Behavioral characterization of mouse models for Smith-Magenis syndrome and dup(17)(p11.2p11.2).

Authors:  Katherina Walz; Corinne Spencer; Krista Kaasik; Cheng C Lee; James R Lupski; Richard Paylor
Journal:  Hum Mol Genet       Date:  2004-01-06       Impact factor: 6.150

10.  [Inversion of the circadian melatonin rhythm in Smith-Magenis syndrome].

Authors:  H De Leersnyder; M-C de Blois; J-L Bresson; D Sidi; B Claustrat; A Munnich
Journal:  Rev Neurol (Paris)       Date:  2003-11       Impact factor: 2.607

View more
  39 in total

Review 1.  Yin-yang actions of histone methylation regulatory complexes in the brain.

Authors:  Patricia Marie Garay; Margarete Aryanka Wallner; Shigeki Iwase
Journal:  Epigenomics       Date:  2016-11-18       Impact factor: 4.778

Review 2.  Circadian topology of metabolism.

Authors:  Joseph Bass
Journal:  Nature       Date:  2012-11-15       Impact factor: 49.962

Review 3.  Minutes, days and years: molecular interactions among different scales of biological timing.

Authors:  Diego A Golombek; Ivana L Bussi; Patricia V Agostino
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-01-20       Impact factor: 6.237

4.  Twenty-four-hour motor activity and body temperature patterns suggest altered central circadian timekeeping in Smith-Magenis syndrome, a neurodevelopmental disorder.

Authors:  Ann C M Smith; Rebecca S Morse; Wendy Introne; Wallace C Duncan
Journal:  Am J Med Genet A       Date:  2019-02       Impact factor: 2.802

5.  MBD5 haploinsufficiency is associated with sleep disturbance and disrupts circadian pathways common to Smith-Magenis and fragile X syndromes.

Authors:  Sureni V Mullegama; Loren Pugliesi; Brooke Burns; Zalak Shah; Raiha Tahir; Yanghong Gu; David L Nelson; Sarah H Elsea
Journal:  Eur J Hum Genet       Date:  2014-10-01       Impact factor: 4.246

6.  Identification of Nine New RAI1-Truncating Mutations in Smith-Magenis Syndrome Patients without 17p11.2 Deletions.

Authors:  C Dubourg; F Bonnet-Brilhault; A Toutain; C Mignot; A Jacquette; A Dieux; M Gérard; M-P Beaumont-Epinette; S Julia; B Isidor; M Rossi; S Odent; C Bendavid; C Barthélémy; A Verloes; V David
Journal:  Mol Syndromol       Date:  2014-01-07

7.  Molecular and Neural Functions of Rai1, the Causal Gene for Smith-Magenis Syndrome.

Authors:  Wei-Hsiang Huang; Casey J Guenthner; Jin Xu; Tiffany Nguyen; Lindsay A Schwarz; Alex W Wilkinson; Or Gozani; Howard Y Chang; Mehrdad Shamloo; Liqun Luo
Journal:  Neuron       Date:  2016-09-29       Impact factor: 17.173

Review 8.  Rhythms of life: circadian disruption and brain disorders across the lifespan.

Authors:  Ryan W Logan; Colleen A McClung
Journal:  Nat Rev Neurosci       Date:  2019-01       Impact factor: 34.870

9.  Dream enactment behavior: review for the clinician.

Authors:  Marc Baltzan; Chun Yao; Dorrie Rizzo; Ron Postuma
Journal:  J Clin Sleep Med       Date:  2020-11-15       Impact factor: 4.062

10.  Circadian abnormalities in mouse models of Smith-Magenis syndrome: evidence for involvement of RAI1.

Authors:  Melanie Lacaria; Wenli Gu; James R Lupski
Journal:  Am J Med Genet A       Date:  2013-05-23       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.